FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes Life Science Investing
VistaGen Therapeutics Receives Hong Kong Patent for Methods of Production for AV-101 Pharmaceutical Investing
Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors Pharmaceutical Investing
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs Life Science Investing
Ascendis Pharma Announces Positive Preliminary Phase 1 Data for TransCon CNP Pharmaceutical Investing
Antibe Therapeutics Announces Successful Completion of Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346 Pharmaceutical Investing
PreveCeutical Responds to British Columbia Securities Commission Press Release Cannabis Investing News
